BioCentury
ARTICLE | Clinical News

Lyrica pregabalin regulatory update

April 3, 2006 7:00 AM UTC

EC approved Lyrica pregabalin to treat generalized anxiety disorder (GAD) in adults. The GABA analog already is marketed for neuropathic pain, including peripheral, diabetic and postherpetic neuropath...